Incidence of Nephrotoxicity Among Pediatric Patients Receiving Vancomycin With Either Piperacillin–Tazobactam or Cefepime: A Cohort Study
2018 ◽
Vol 8
(3)
◽
pp. 221-227
◽
Keyword(s):
In this matched-cohort study of pediatric inpatients, 28.9% of those treated with a combination of piperacillin–tazobactam and vancomycin developed acute kidney injury, compared to 7.9% in those treated with cefepime and vancomycin (P < .001).
Keyword(s):
Keyword(s):
Keyword(s):
2016 ◽
Vol 31
(11)
◽
pp. 1846-1854
◽
Keyword(s):
Keyword(s):
2017 ◽
Keyword(s):
Keyword(s):